MA31252B1 - Macrolides a base d'erythromycine - Google Patents
Macrolides a base d'erythromycineInfo
- Publication number
- MA31252B1 MA31252B1 MA32219A MA32219A MA31252B1 MA 31252 B1 MA31252 B1 MA 31252B1 MA 32219 A MA32219 A MA 32219A MA 32219 A MA32219 A MA 32219A MA 31252 B1 MA31252 B1 MA 31252B1
- Authority
- MA
- Morocco
- Prior art keywords
- erythromycin
- macrolides
- based macrolides
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La présente invention concerne des composés de formule (i), r1, r2, et x étant tels que définis ici. La présente invention concerne également des compositions pharmaceutiques et des procédés de traitement d'infections bactériennes au moyen des composés de formule (i).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89447507P | 2007-03-13 | 2007-03-13 | |
US2337008P | 2008-01-24 | 2008-01-24 | |
PCT/IB2008/000715 WO2008110918A2 (fr) | 2007-03-13 | 2008-03-04 | Macrolides |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31252B1 true MA31252B1 (fr) | 2010-03-01 |
Family
ID=39760163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32219A MA31252B1 (fr) | 2007-03-13 | 2009-09-11 | Macrolides a base d'erythromycine |
Country Status (28)
Country | Link |
---|---|
US (1) | US20080293646A1 (fr) |
EP (1) | EP2125851B1 (fr) |
JP (1) | JP4468487B1 (fr) |
KR (1) | KR20090110381A (fr) |
CN (1) | CN101631795A (fr) |
AP (1) | AP2009004985A0 (fr) |
AR (1) | AR065724A1 (fr) |
AT (1) | ATE471943T1 (fr) |
AU (1) | AU2008224633A1 (fr) |
BR (1) | BRPI0809002A2 (fr) |
CA (1) | CA2680527A1 (fr) |
CL (1) | CL2008000695A1 (fr) |
CR (1) | CR10998A (fr) |
CU (1) | CU20090155A7 (fr) |
DE (1) | DE602008001611D1 (fr) |
DO (1) | DOP2009000214A (fr) |
EA (1) | EA200901059A1 (fr) |
EC (1) | ECSP099627A (fr) |
IL (1) | IL200613A0 (fr) |
MA (1) | MA31252B1 (fr) |
MX (1) | MX2009009074A (fr) |
PA (1) | PA8772401A1 (fr) |
PE (1) | PE20090106A1 (fr) |
SV (1) | SV2009003368A (fr) |
TN (1) | TN2009000374A1 (fr) |
TW (1) | TW200848061A (fr) |
UY (1) | UY30957A1 (fr) |
WO (1) | WO2008110918A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104169286B (zh) * | 2012-03-06 | 2016-06-08 | 辉瑞大药厂 | 用于治疗增殖性疾病的大环衍生物 |
JP6437523B2 (ja) | 2013-04-04 | 2018-12-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | マクロライドならびにそれらの調製および使用の方法 |
US10633407B2 (en) | 2014-10-08 | 2020-04-28 | President And Fellows Of Harvard College | 14-membered ketolides and methods of their preparation and use |
EP3273969A4 (fr) | 2015-03-25 | 2018-11-21 | President and Fellows of Harvard College | Macrolides à sucres modifiés de type désosamine et utilisations de ceux-ci |
CN105924451B (zh) * | 2016-04-27 | 2017-12-15 | 国家海洋局第三海洋研究所 | 具有抗茶叶致病真菌活性的大环内酯化合物及制备与用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1836211E (pt) * | 2004-12-21 | 2010-04-08 | Pfizer Prod Inc | Macrólidos |
-
2008
- 2008-03-04 AP AP2009004985A patent/AP2009004985A0/xx unknown
- 2008-03-04 AU AU2008224633A patent/AU2008224633A1/en not_active Abandoned
- 2008-03-04 EP EP08719365A patent/EP2125851B1/fr active Active
- 2008-03-04 CA CA002680527A patent/CA2680527A1/fr not_active Abandoned
- 2008-03-04 KR KR1020097019014A patent/KR20090110381A/ko not_active Application Discontinuation
- 2008-03-04 MX MX2009009074A patent/MX2009009074A/es not_active Application Discontinuation
- 2008-03-04 DE DE602008001611T patent/DE602008001611D1/de active Active
- 2008-03-04 AT AT08719365T patent/ATE471943T1/de not_active IP Right Cessation
- 2008-03-04 EA EA200901059A patent/EA200901059A1/ru unknown
- 2008-03-04 WO PCT/IB2008/000715 patent/WO2008110918A2/fr active Application Filing
- 2008-03-04 CN CN200880008148A patent/CN101631795A/zh active Pending
- 2008-03-04 CU CU20090155A patent/CU20090155A7/es unknown
- 2008-03-04 BR BRPI0809002-5A2A patent/BRPI0809002A2/pt not_active IP Right Cessation
- 2008-03-04 JP JP2009553232A patent/JP4468487B1/ja active Active
- 2008-03-07 CL CL200800695A patent/CL2008000695A1/es unknown
- 2008-03-11 PE PE2008000454A patent/PE20090106A1/es not_active Application Discontinuation
- 2008-03-12 TW TW097108663A patent/TW200848061A/zh unknown
- 2008-03-12 US US12/047,154 patent/US20080293646A1/en not_active Abandoned
- 2008-03-12 UY UY30957A patent/UY30957A1/es not_active Application Discontinuation
- 2008-03-13 PA PA20088772401A patent/PA8772401A1/es unknown
- 2008-03-13 AR ARP080101036A patent/AR065724A1/es unknown
-
2009
- 2009-08-26 CR CR10998A patent/CR10998A/es unknown
- 2009-08-27 IL IL200613A patent/IL200613A0/en unknown
- 2009-09-08 DO DO2009000214A patent/DOP2009000214A/es unknown
- 2009-09-11 MA MA32219A patent/MA31252B1/fr unknown
- 2009-09-11 SV SV2009003368A patent/SV2009003368A/es not_active Application Discontinuation
- 2009-09-11 TN TNP2009000374A patent/TN2009000374A1/fr unknown
- 2009-09-11 EC EC2009009627A patent/ECSP099627A/es unknown
Also Published As
Publication number | Publication date |
---|---|
TN2009000374A1 (fr) | 2010-12-31 |
AP2009004985A0 (en) | 2009-10-31 |
BRPI0809002A2 (pt) | 2014-11-11 |
EA200901059A1 (ru) | 2010-02-26 |
JP4468487B1 (ja) | 2010-05-26 |
ATE471943T1 (de) | 2010-07-15 |
CA2680527A1 (fr) | 2008-09-18 |
CN101631795A (zh) | 2010-01-20 |
IL200613A0 (en) | 2010-05-17 |
AU2008224633A1 (en) | 2008-09-18 |
TW200848061A (en) | 2008-12-16 |
MX2009009074A (es) | 2009-09-28 |
WO2008110918A2 (fr) | 2008-09-18 |
UY30957A1 (es) | 2008-10-31 |
CL2008000695A1 (es) | 2008-09-22 |
PE20090106A1 (es) | 2009-02-08 |
EP2125851A2 (fr) | 2009-12-02 |
ECSP099627A (es) | 2009-10-30 |
WO2008110918A3 (fr) | 2009-01-29 |
JP2010521448A (ja) | 2010-06-24 |
US20080293646A1 (en) | 2008-11-27 |
PA8772401A1 (es) | 2008-11-19 |
DE602008001611D1 (en) | 2010-08-05 |
SV2009003368A (es) | 2009-11-09 |
KR20090110381A (ko) | 2009-10-21 |
DOP2009000214A (es) | 2009-10-31 |
CU20090155A7 (es) | 2011-04-26 |
AR065724A1 (es) | 2009-06-24 |
EP2125851B1 (fr) | 2010-06-23 |
CR10998A (es) | 2009-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA32615B1 (fr) | Inhibiteurs de cmet | |
MA45222A (fr) | Nouveaux dérivés de pipéridinyle, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant | |
MA33642B1 (fr) | Composés chimiques | |
MA35104B1 (fr) | Inhibiteur du virus de l'hepatite c | |
MA33731B1 (fr) | Inhibiteurs du virus de l'hépatite c | |
MA31763B1 (fr) | Inhibiteurs de kinase de type polo | |
MA34896B1 (fr) | Inhibiteurs du virus de l'hepatite c | |
MA31496B1 (fr) | Inhibiteurs macrocycliques innovants de la replication du virus de l'hepatite c | |
MA32941B1 (fr) | Composes organiques | |
MA37891B1 (fr) | Alcoxypyrazoles comme activateurs de guanylate cyclase soluble | |
MA30784B1 (fr) | Derives phenyliques et utilisation de ceux-ci en tant qu'immunomodulateurs. | |
MA30226B1 (fr) | Agents cytotoxiques comprenant de nouveaux derives de tomaymycine et leur utilisation therapeutique. | |
MA33420B1 (fr) | Dérivés fluorés de l'aminotriazole | |
MA32104B1 (fr) | Dérivés d'oxime en tant qu'inhibiteurs de hsp90 | |
MA33119B1 (fr) | Derives de benzofuranyle utilises comme inhibiteurs de la glucokinase | |
MA30352B1 (fr) | Pyridine [3,4-b] pyrazinones | |
MX2009003821A (es) | Compuestos de n-aril pirazol para usarse contra la diabetes. | |
MA32509B1 (fr) | Composes organiques | |
MA34819B1 (fr) | Dérivés bicyclo[3.2.1]octylamide et leurs utilisations | |
MA31151B1 (fr) | Inhibiteurs de mapk/erk kinase | |
TNSN07305A1 (fr) | Agonistes de pyy et leurs utilisations | |
MA31906B1 (fr) | Inhibiteurs de la replication du virus de limmunodeficience humaine | |
MA31574B1 (fr) | Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf | |
MA32929B1 (fr) | Lactames en tant qu'inhibiteurs de bêta-sécrétase | |
TNSN08137A1 (fr) | Derives de carboxamides servant d'antagonistes des recepteurs muscariniques |